{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:50:44Z","timestamp":1792507844297,"version":"4.5.0"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003061","name":"Erasmus Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of fluorescent probes that target the tumor stroma to help surgeons detect and remove malignant lesions using near-infrared fluorescence (NIRF)-guided surgery is advancing rapidly. Such advancements show promise for a range of malignancies, expanding the eligibility of patients for surgical intervention and offering improved surgical outcomes. Fibroblast activation protein (FAP), expressed by cancer-associated fibroblasts (CAFs), is highly upregulated within the tumor stroma of nearly all solid tumors. It is a promising tumor target for NIRF-guided surgery, especially in solid tumors with dense tumor stroma, such as pancreatic cancer. In this study, we aimed to develop FAP-targeting fluorescent probes with enhanced pharmacokinetics for the NIRF-guided surgery of pancreatic cancer. Three novel FAP-targeted probes (eFAPs) based on a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine (QCP) structure equipped with the NIRF dye IRDye800CW were designed and synthesized. All of the probes displayed excellent inhibition potency and selectivity to FAP. The probes consistently exhibited strong inhibition and specific uptake in FAP-expressing U87 glioblastoma cells. In in vivo optical imaging studies, eFAP-24 showed a tumor-to-background ratio (TBR) of 3.1 \u00b1 0.6 at 24 h postinjection, enabling the clear delineation of tumors using the clinical Quest Spectrum NIRF imaging system. A strong fluorescence signal in the tumor and a negligible uptake in nontarget tissues were confirmed by biodistribution analyses. The successful development and validation of FAP-targeting fluorescent probes, especially eFAP-24, offers promising prospects for enhancing the visualization of FAP-rich stromal compartments improving surgical outcomes through NIRF-guided surgery, particularly in solid tumors with dense stroma such as pancreatic cancer.<\/jats:p>","DOI":"10.1021\/acs.bioconjchem.5c00218","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:39:13Z","timestamp":1759361953000},"page":"2145-2157","source":"Crossref","is-referenced-by-count":4,"title":["Revolutionizing\nSolid Tumor Surgery with Fibroblast\nActivation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided\nSurgery of Pancreatic Cancer"],"prefix":"10.1021","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7307-0388","authenticated-orcid":true,"given":"Hanyue","family":"Ma","sequence":"first","affiliation":[{"name":"Erasmus Medical Center , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus Medical Center Cancer Institute , ,","place":["Rotterdam, The Netherlands, 3015 CP"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne D. A. N.","family":"de Muynck","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben D.","family":"Houvast","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savanne","family":"Beekman","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus Medical Center Cancer Institute , ,","place":["Rotterdam, The Netherlands, 3015 CP"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Piet","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus Medical Center Cancer Institute , ,","place":["Rotterdam, The Netherlands, 3015 CP"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn L.","family":"March","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas J. A. C.","family":"Hawinkels","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Sven D.","family":"Mieog","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center , , ,","place":["Leiden, The Netherlands, 2333 ZA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-5318","authenticated-orcid":true,"given":"Yann","family":"Seimbille","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus Medical Center Cancer Institute , ,","place":["Rotterdam, The Netherlands, 3015 CP"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026100102061127400_cit1","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.1038\/s41598-020-73525-y","article-title":"The actual 5-year survivors of pancreatic\nductal adenocarcinoma based on real-world data","volume":"10","author":"Bengtsson","year":"2020","journal-title":"Sci. Rep."},{"key":"2026100102061127400_cit2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jso.24092","article-title":"The importance of\nsurgical margins in pancreatic cancer","volume":"113","author":"Ethun","year":"2016","journal-title":"J. Surg.\nOncol."},{"key":"2026100102061127400_cit3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-021-00548-3","article-title":"Fundamentals\nand developments in fluorescence-guided cancer surgery","volume":"19","author":"Mieog","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026100102061127400_cit4","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3390\/cancers13205246","article-title":"Cancer-Associated\nFibroblast Functions\nas a Road-Block in Cancer Therapy","volume":"13","author":"De","year":"2021","journal-title":"Cancers"},{"key":"2026100102061127400_cit5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-011-9340-x","article-title":"Cancer-associated-fibroblasts and tumour cells: a diabolic\nliaison driving cancer progression","volume":"31","author":"Cirri","year":"2012","journal-title":"Cancer Metastasis\nRev."},{"key":"2026100102061127400_cit6","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface\nglycoprotein of reactive\nstromal fibroblasts as a potential antibody target in human epithelial\ncancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026100102061127400_cit7","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1152\/physrev.00042.2019","article-title":"Microenvironmental\nDeterminants of\nPancreatic Cancer","volume":"100","author":"Hessmann","year":"2020","journal-title":"Physiol. Rev."},{"key":"2026100102061127400_cit8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-022-00530-w","article-title":"Epithelial\nand stromal co-evolution and complicity in pancreatic cancer","volume":"23","author":"Hingorani","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"2026100102061127400_cit9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/cancers12051347","article-title":"Pancreatic\nCancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic\nCancer Treatment","volume":"12","author":"Norton","year":"2020","journal-title":"Cancers"},{"key":"2026100102061127400_cit10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1039\/C4MD00167B","article-title":"Selective inhibitors of fibroblast activation protein\n(FAP) with a xanthine scaffold","volume":"5","author":"Jansen","year":"2014","journal-title":"Medchemcomm"},{"key":"2026100102061127400_cit11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development\nof Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast\nActivation Protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"key":"2026100102061127400_cit12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/thno.69475","article-title":"Fibroblast activation\nprotein-based theranostics in cancer research: A state-of-the-art\nreview","volume":"12","author":"Zhao","year":"2022","journal-title":"Theranostics"},{"key":"2026100102061127400_cit13","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1007\/s00259-023-06297-y","article-title":"Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET\/CT\nand [18F]F-FDG PET\/CT in pancreatic ductal adenocarcinoma: additional\nprognostic value of the distal pancreatitis","volume":"50","author":"Ding","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026100102061127400_cit14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","article-title":"Impact\nof 68Ga-FAPI PET\/CT Imaging on the Therapeutic Management of Primary\nand Recurrent Pancreatic Ductal Adenocarcinomas","volume":"62","author":"Rohrich","year":"2021","journal-title":"J. Nucl. Med."},{"key":"2026100102061127400_cit15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s41181-024-00283-x","article-title":"In vitro and in vivo analyses of eFAP: a novel FAP-targeting\nsmall molecule for radionuclide theranostics and other oncological\ninterventions","volume":"9","author":"van der Heide","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"2026100102061127400_cit16","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.3390\/cancers13236088","article-title":"Overview and\nFuture Perspectives on Tumor-Targeted Positron Emission Tomography\nand Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant\nTherapy","volume":"13","author":"van Dam","year":"2021","journal-title":"Cancers"},{"key":"2026100102061127400_cit17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting\nthe tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol. Cancer"},{"key":"2026100102061127400_cit18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/biomedicines12030591","article-title":"Cancer-Associated Fibroblasts in\nPancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity:\nFrom Single-Cell Analysis to Whole-Body Imaging","volume":"12","author":"Sau\u0301de-Conde","year":"2024","journal-title":"Biomedicines"},{"key":"2026100102061127400_cit19","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00259-023-06407-w","article-title":"Preclinical evaluation\nof EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting\nmoieties for bimodal near-infrared fluorescence and photoacoustic\nimaging of cancer","volume":"51","author":"Houvast","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026100102061127400_cit20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s11307-020-01522-8","article-title":"Glycan-based\nnear-infrared fluorescent (NIRF) imaging of gastrointestinal tumors:\na preclinical proof-of-concept in vivo study","volume":"22","author":"Houvast","year":"2020","journal-title":"Mol. Imaging Biol."},{"key":"2026100102061127400_cit21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2021.01.001","article-title":"A multimodal\nmolecular imaging approach targeting urokinase\nplasminogen activator receptor for the diagnosis, resection and surveillance\nof urothelial cell carcinoma","volume":"146","author":"Baart","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"2026100102061127400_cit22","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-19-4156","article-title":"First-in-human assessment of cRGD-ZW800\u20131,\na zwitterionic, integrin-targeted, near-infrared fluorescent peptide\nin colon carcinoma","volume":"26","author":"de Valk","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"2026100102061127400_cit23","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1245\/s10434-020-09069-2","article-title":"Dose-finding\nstudy of a CEA-targeting agent, SGM-101, for intraoperative fluorescence\nimaging of colorectal cancer","volume":"28","author":"de Valk","year":"2021","journal-title":"Oncol"},{"key":"2026100102061127400_cit24","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/1078-0432.ccr-24-0940","article-title":"Interim\nPhase II Results Using Panitumumab-IRDye800CW during Transoral Robotic\nSurgery in Patients with Oropharyngeal Cancer","volume":"30","author":"Stone","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"2026100102061127400_cit25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12885-024-12859-6","article-title":"Study protocol for\nNear-infrared molecular imaging\nfor lung cancer detection and treatment during mini-invasive surgery\n(phase II Trial) - (the RECOGNISE study)","volume":"24","author":"Beffa","year":"2024","journal-title":"BMC\nCancer"},{"key":"2026100102061127400_cit26","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00259-024-06713-x","article-title":"First-in-man study of the PSMA Minibody\nIR800-IAB2M for molecularly targeted intraoperative fluorescence guidance\nduring radical prostatectomy","volume":"51","author":"Hamdy","year":"2024","journal-title":"Eur. J. Nucl.\nMed. Mol. Imaging"},{"key":"2026100102061127400_cit27","doi-asserted-by":"publisher","first-page":"16211","DOI":"10.1038\/s41598-020-73242-6","article-title":"Molecular\ntargets for diagnostic and intraoperative imaging of pancreatic ductal\nadenocarcinoma after neoadjuvant FOLFIRINOX treatment","volume":"10","author":"Vuijk","year":"2020","journal-title":"Sci. Rep."},{"key":"2026100102061127400_cit28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fonc.2020.00620","article-title":"Biochemical\nPredictors of Response to Neoadjuvant Therapy in Pancreatic Ductal\nAdenocarcinoma","volume":"10","author":"Awad","year":"2020","journal-title":"Front. Oncol."},{"key":"2026100102061127400_cit29","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/jco.21.02233","article-title":"Neoadjuvant\nChemoradiotherapy Versus Upfront Surgery for Resectable and Borderline\nResectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized\nPREOPANC Trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"2026100102061127400_cit30","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1021\/acs.jmedchem.0c02171","article-title":"Imaging\nof Fibroblast Activation Protein in Cancer Xenografts Using Novel\n(4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules HHS\nPublic Access","volume":"64","author":"Slania","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026100102061127400_cit31","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.gastha.2022.04.019","article-title":"A Novel Pancreatic Cancer Mini-tumor\nModel to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast\nDifferentiation","volume":"1","author":"Harryvan","year":"2022","journal-title":"Gastro Hep Adv."}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.bioconjchem.5c00218","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/36\/10\/2145\/68722287\/acs.bioconjchem.5c00218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/36\/10\/2145\/68722287\/acs.bioconjchem.5c00218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:12:23Z","timestamp":1790842343000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bcches\/article\/36\/10\/2145\/3675220\/Revolutionizing-Solid-Tumor-Surgery-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,10,15]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.bioconjchem.5c00218","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}